Designing Rigid Peptide Building Blocks for More Stable, Orally Available Peptide Drugs
ACBC-containing model peptides adopted characteristic stable conformations that could improve peptide drug stability and oral bioavailability.
Quick Facts
What This Study Found
ACBC-containing model peptides adopted characteristic stable conformations (helical and extended) that could be leveraged for peptide drug design.
Key Numbers
How They Did This
Molecular mechanics calculations on model peptides containing ACBC and its derivatives to determine low-energy conformations and compare them to natural amino acid peptides.
Why This Research Matters
One of the biggest challenges in peptide drug development is that peptides are floppy and easily broken down. Constrained building blocks like ACBC help solve both problems by locking peptides into stable, active shapes.
The Bigger Picture
Making peptides that survive digestion and can be taken as pills is a holy grail of drug development. Constrained building blocks like ACBC help solve this by making peptides resistant to enzymatic breakdown.
What This Study Doesn't Tell Us
Computational modeling study without experimental validation. Predicted conformations need to be confirmed by actual structural studies like NMR or X-ray crystallography.
Questions This Raises
- ?Have ACBC-containing peptides been validated experimentally?
- ?Can this approach be applied to opioid peptide drug design?
Trust & Context
- Key Stat:
- Conformational constraint ACBC residues forced peptides into predictable stable conformations — helical or extended — that resist degradation
- Evidence Grade:
- Preliminary — computational study without experimental validation. Predicted conformations need structural confirmation.
- Study Age:
- Published in 1995 (31 years ago). Constrained peptidomimetics have since become a major area of drug design.
- Original Title:
- Conformational studies on model peptides with 1-aminocyclobutane 1-carboxylic acid residues.
- Published In:
- Peptide research, 8(3), 178-86 (1995)
- Authors:
- Balaji, V N, Ramnarayan, K, Chan, M F, Rao, S N
- Database ID:
- RPEP-00314
Evidence Hierarchy
Frequently Asked Questions
Why are peptide drugs hard to take as pills?
Peptides are quickly broken down by stomach acid and digestive enzymes, and they're too large to easily cross the gut wall. Using rigid building blocks like ACBC makes peptides more resistant to breakdown and potentially absorbable.
What is a peptidomimetic?
A peptidomimetic is a molecule designed to mimic a natural peptide's biological activity but with improved drug properties — better stability, oral absorption, and resistance to enzymatic degradation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00314APA
Balaji, V N; Ramnarayan, K; Chan, M F; Rao, S N. (1995). Conformational studies on model peptides with 1-aminocyclobutane 1-carboxylic acid residues.. Peptide research, 8(3), 178-86.
MLA
Balaji, V N, et al. "Conformational studies on model peptides with 1-aminocyclobutane 1-carboxylic acid residues.." Peptide research, 1995.
RethinkPeptides
RethinkPeptides Research Database. "Conformational studies on model peptides with 1-aminocyclobu..." RPEP-00314. Retrieved from https://rethinkpeptides.com/research/balaji-1995-conformational-studies-on-model
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.